ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "C01EB" (41)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Crataegus Glycosides (C01EB04) 18 products WHO-DDD DrugBank.ca 
   CIPhFaros 30050 Dragée(s)6.1311.3010 %Dragées: Crataegi Folii Cum Flore Extractum Methanolicum Siccum 300 mgOM Pharma Suisse SAD / SLG
   CIPhFaros 300100 Dragée(s)11.3320.9010 %Dragées: Crataegi Folii Cum Flore Extractum Methanolicum Siccum 300 mgOM Pharma Suisse SAD / SLG
   CIPhCardiplant 45050 Tablet(s)12.2622.6510 %Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mgSchwabe Pharma AGD / SLG
   CIPhCardiplant 4506014.3626.5010 %Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mgSchwabe Pharma AGD / SLG
   CIPhCardiplant 450100 Tablet(s)21.5839.8510 %Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mgSchwabe Pharma AGD / SLG
   CIPhCardiplant 45012025.5447.1510 %Coated tablets: Crataegi Folii Cum Flore Extractum Ethanolicum Siccum 450 mgSchwabe Pharma AGD / SLG
   CIPhSidroga Weissdorn20 x 1.5 gk.A.Chopped herbs: Crataegi Folium Cum Flore 1.5 gUriach Switzerland AGDG
   CIPhArkocaps Aubépine 350 mg45k.A.Capsules: Crataegi Folium cum Flore Pulvis 350 mgArko Diffusion AGDG
   CIPhCrataegisan50 ml14.80k.A.Drops: Crataegi Fructus Recentis Tinctura 970 mg/mlA.Vogel AGDG
   CIPhCrataegisan100 ml25.80k.A.Drops: Crataegi Fructus Recentis Tinctura 970 mg/mlA.Vogel AGDG
   CIPhCrataegus Synpha50 ml12.50k.A.Drops: Crataegi Extractum Ethanolicum LiquidumHänseler AGDG
   CIPhCrataegus Synpha100 ml16.70k.A.Drops: Crataegi Extractum Ethanolicum LiquidumHänseler AGDG
   CI Cardiplant50 Coated tablet(s)14.10k.A.Coated tablets: 3 Active AgentsSchwabe Pharma AGDG
   CI Cardiplant100 Coated tablet(s)24.80k.A.Coated tablets: 3 Active AgentsSchwabe Pharma AGDG
   CI Cardiplant50 mlk.A.Drops: 2 Active AgentsSchwabe Pharma AGDG
   CI Cardiplant100 mlk.A.Drops: 2 Active AgentsSchwabe Pharma AGDG
   CI Sedosan-N50 mlk.A.Drops: Crataegi Herbae Extractum Liquidum 240 mgDr. Grossmann AG
Pharmaca
DG
   CI Sedosan-N100 mlk.A.Drops: Crataegi Herbae Extractum Liquidum 240 mgDr. Grossmann AG
Pharmaca
DG
Adenosine (C01EB10) 1 products WHO-DDD DrugBank.ca 
  IP  Krenosin6 1 ampoule(s) à 2 ml82.55k.A.Injection solution: Adenosinum 6mg / 2mlSanofi-Aventis
(Suisse) SA
● AG
Ivabradine (C01EB17) 8 products WHO-DDD DrugBank.ca 
LSIPIPCI Procoralan 5 mg56 Tablet(s)29.0247.8010 %Coated tablets: Ivabradinum 5 mgServier (Suisse) SAB / SL / SOG
LSIPIPCI Procoralan 5 mg112 Tablet(s)57.8978.9510 %Coated tablets: Ivabradinum 5 mgServier (Suisse) SAB / SL / SOG
LSIPIPCI Procoralan 7.5 mg56 Tablet(s)29.0247.8010 %Coated tablets: Ivabradinum 7.5 mgServier (Suisse) SAB / SL / SOG
LSIPIPCI Procoralan 7.5 mg112 Tablet(s)57.8978.9510 %Coated tablets: Ivabradinum 7.5 mgServier (Suisse) SAB / SL / SOG
L IPCI Ivabradin Viatris 5 mg5623.2241.8510 %Coated tablets: Ivabradinum 5 mgViatris Pharma GmbHB / SL / SGG
L IPCI Ivabradin Viatris 5 mg11246.3167.1010 %Coated tablets: Ivabradinum 5 mgViatris Pharma GmbHB / SL / SGG
L IPCI Ivabradin Viatris 7.5 mg5623.2241.8510 %Coated tablets: Ivabradinum 7.5 mgViatris Pharma GmbHB / SL / SGG
L IPCI Ivabradin Viatris 7.5 mg11246.3167.1010 %Coated tablets: Ivabradinum 7.5 mgViatris Pharma GmbHB / SL / SGG
Ranolazine (C01EB18) 9 products WHO-DDD DrugBank.ca 
L IPCI Ranexa 375 mg60 Tablet(s)46.3166.8010 %Delayed release tablets: Ranolazinum 375 mgA. Menarini GmbHB / SLG
L IPCI Ranexa 375 mg100 Tablet(s)75.7398.8010 %Delayed release tablets: Ranolazinum 375 mgA. Menarini GmbHB / SLG
L IPCI Ranexa 500 mg60 Tablet(s)46.3166.8010 %Delayed release tablets: Ranolazinum 500 mgA. Menarini GmbHB / SLG
L IPCI Ranexa 500 mg100 Tablet(s)75.7398.8010 %Delayed release tablets: Ranolazinum 500 mgA. Menarini GmbHB / SLG
L IPCI Ranexa 750 mg60 Tablet(s)46.3166.8010 %Delayed release tablets: Ranolazinum 750 mgA. Menarini GmbHB / SLG
L IPCI Ranexa 750 mg100 Tablet(s)75.7398.8010 %Delayed release tablets: Ranolazinum 750 mgA. Menarini GmbHB / SLG
  IPCI Ranexa 375 mg30 Tablet(s)k.A.Delayed release tablets: Ranolazinum 375 mgA. Menarini GmbHBG
  IPCI Ranexa 500 mg30 Tablet(s)k.A.Delayed release tablets: Ranolazinum 500 mgA. Menarini GmbHBG
  IPCI Ranexa 750 mg30 Tablet(s)k.A.Delayed release tablets: Ranolazinum 750 mgA. Menarini GmbHBG
Regadenoson (C01EB21) 1 products WHO-DDD  
  IP  Rapiscan 400 µg/ 5 ml 90.30114.6010 %Injection solution: Regadenosonum 400µg / 5mlGE Healthcare AGA / SLG
Mavacamten (C01EB24) 4 products WHO-DDD  
L IPCI Camzyos 2.5 mg281250.151376.0510 %Capsules: Mavacamtenum 2.5 mgBristol-Myers Squibb SAB / SLG
L IPCI Camzyos 5 mg281250.151376.0510 %Capsules: Mavacamtenum 5 mgBristol-Myers Squibb SAB / SLG
L IPCI Camzyos 10 mg281250.151376.0510 %Capsules: Mavacamtenum 10 mgBristol-Myers Squibb SAB / SLG
L IPCI Camzyos 15 mg281250.151376.0510 %Capsules: Mavacamtenum 15 mgBristol-Myers Squibb SAB / SLG
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home